Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Pain Reduction Following Treatment of Bleeding Episodes with Eptacog Beta in Adults and Adolescents with Hemophilia A or B Complicated By Inhibitors

Tyler W. Buckner, Craig Kessler, Giancarlo Castaman, Cédric Hermans, Victor Jimenez-Yuste, Johnny Mahlangu, Wolfgang A. Miesbach, Johannes Oldenburg, Michael Recht, Leonard A. Valentino, Allison P Wheeler, Steven W. Pipe

Blood (2024) 144 (Supplement 1): 3972.

https://doi.org/10.1182/blood-2024-194935

Published: 2024

Journal Articles

Indirect Comparison of the Efficacy and Therapy-Related Costs of a Pharmacokinetic and Individualized Prophylaxis Regimen with Simoctocog Alfa Versus Other Extended-Half Life Factor VIII Concentrates

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D Tarantino

Blood (2024) 144 (Supplement 1): 2592.

https://doi.org/10.1182/blood-2024-193880

Published: 2024

Journal Articles

Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (<12 years) with Hemophilia a or B with Inhibitors

Blood (2023) 142 (Supplement 1): 5480.

https://doi.org/10.1182/blood-2023-181299

Published: 2023

Journal Articles

Timing of Thrombosis with Myeloproliferative Neoplasm Diagnosis Among Veterans and Civilians

Michelle Zimmerman, Andrew Tiu, George Sidarous, Joseph An, Zoe McKinnell, Puneet Gill, Martha Antonio, Shanshan Liu, Guoqing Diao, Ramesh Subrahmanyam, Craig Kessler, Maneesh Rajiv Jain

Blood (2023) 142 (Supplement 1): 6407.

https://doi.org/10.1182/blood-2023-189121

Published: 2023

Journal Articles

Thrombosis and Bleeding Outcomes Among Veterans with Chronic Myeloid Leukemia and Association with Agent Orange Exposure

Matthew Rosenthal, Zoe McKinnell, Andrew Tiu, Daniel Tuerff, Puneet Gill, Martha Antonio, Shanshan Liu, Guoqing Diao, Ramesh Subrahmanyam, Craig Kessler, Maneesh Rajiv Jain

Blood (2023) 142 (Supplement 1): 6373.

https://doi.org/10.1182/blood-2023-190883

Published: 2023

Journal Articles

Cardiovascular Outcomes Among Myeloproliferative Neoplasm Patients with or without Agent Orange Exposure Using a Large Veteran Database

Andrew Tiu, Zoe McKinnell, Puneet Gill, Martha Antonio, Zoe Shancer, Nandan Srinivasa, Shanshan Liu, Guoqing Diao, Ramesh Subrahmanyam, Craig Kessler, Maneesh Rajiv Jain

Blood (2023) 142 (Supplement 1): 3202.

https://doi.org/10.1182/blood-2023-190930

Published: 2023

Journal Articles

Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D. Tarantino

Blood (2023) 142 (Supplement 1): 5473.

https://doi.org/10.1182/blood-2023-180603

Published: 2023

Journal Articles

Clinical Characteristics and Outcomes of Unusual Venous Thrombosis Sites Among Veterans with Myeloproliferative Neoplasms

Zoe McKinnell, Andrew Tiu, Puneet Gill, Martha Antonio, Shanshan Liu, Guoqing Diao, Ramesh Subrahmanyam, Daniel Tuerff, Craig Kessler, Maneesh Rajiv Jain

Blood (2023) 142 (Supplement 1): 6403.

https://doi.org/10.1182/blood-2023-189999

Published: 2023

Journal Articles

Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D. Tarantino

Blood (2023) 142 (Supplement 1): 5482.

https://doi.org/10.1182/blood-2023-180634

Published: 2023

Journal Articles

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, Alexandra Kruse, Craig Kessler, Caroline Kruse, Andrew D. Leavitt, Alfred I. Lee, Howard A. Liebman, Adrian C. Newland, Ashley E. Ray, Michael D. Tarantino, Jecko Thachil, David J. Kuter, Douglas B. Cines, James B. Bussel

Blood (2022) 139 (10): 1564–1574.

https://doi.org/10.1182/blood.2021013411

Published: 2022

Includes: Supplemental data

Journal Articles

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Blood (2019) 134 (18): 1498–1509.

https://doi.org/10.1182/blood.2019000428

Published: 2019

Includes: Supplemental data

Journal Articles

Hyperhomocysteinemia (HHCY) Increases the Risk for Lower Extremity Ulcers (LEUs).

Blanche H. Mavromatis, MD, Elizabeth M. Gaughan, MD, Bruce D. Cheson, MD, Christopher Attinger, MD, Thomas Cupps, MD, Kara Couch, Katherine Picken, Craig Kessler, MD

Blood (2006) 108 (11): 4099.

https://doi.org/10.1182/blood.V108.11.4099.4099

Published: 2006

Journal Articles

ZAP-70 Expression in Chronic Lymphocytic Leukemia (CLL) Is Independent of Rai Stage: A Retrospective Review of 38 Patients (pts).

Blanche H. Mavromatis, MD, Bruce D. Cheson, MD, Nicole D. Zantek, MD, Dan-Paul Hartmann, PhD, Craig Kessler, MD, Philip Cohen, MD, Edmund Gehan, PhD, Metin Ozdemirli, MD

Blood (2004) 104 (11): 4811.

https://doi.org/10.1182/blood.V104.11.4811.4811

Published: 2004

Journal Articles

Efficacy of Patient Self Testing (PST) for Management of the Hypercoagulable Patient.

Marcia L. Zucker, PhD, Helena Jacobs, Frank M. LaDuca, PhD, Craig Kessler, MD

Blood (2004) 104 (11): 1785.

https://doi.org/10.1182/blood.V104.11.1785.1785

Published: 2004

Journal Articles

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study: Presented in part at the meeting of the International Society of Thrombosis and Haemostasis in Washington, DC, August 1999.

Pier M. Mannucci, Juan Chediak, Wahid Hanna, John Byrnes, Marlies Ledford, Bruce M. Ewenstein, Anastassios D. Retzios, Barbara A. Kapelan, Richard S. Schwartz, Craig Kessler, the Alphanate Study Group

Blood (2002) 99 (2): 450–456.

https://doi.org/10.1182/blood.V99.2.450

Published: 2002

NARROW

Pain Reduction Following Treatment of Bleeding Episodes with Eptacog Beta in Adults and Adolescents with Hemophilia A or B Complicated By Inhibitors

Indirect Comparison of the Efficacy and Therapy-Related Costs of a Pharmacokinetic and Individualized Prophylaxis Regimen with Simoctocog Alfa Versus Other Extended-Half Life Factor VIII Concentrates

Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (<12 years) with Hemophilia a or B with Inhibitors

Timing of Thrombosis with Myeloproliferative Neoplasm Diagnosis Among Veterans and Civilians

Thrombosis and Bleeding Outcomes Among Veterans with Chronic Myeloid Leukemia and Association with Agent Orange Exposure

Cardiovascular Outcomes Among Myeloproliferative Neoplasm Patients with or without Agent Orange Exposure Using a Large Veteran Database

Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a

Clinical Characteristics and Outcomes of Unusual Venous Thrombosis Sites Among Veterans with Myeloproliferative Neoplasms

Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Hyperhomocysteinemia (HHCY) Increases the Risk for Lower Extremity Ulcers (LEUs).

ZAP-70 Expression in Chronic Lymphocytic Leukemia (CLL) Is Independent of Rai Stage: A Retrospective Review of 38 Patients (pts).

Efficacy of Patient Self Testing (PST) for Management of the Hypercoagulable Patient.

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study: Presented in part at the meeting of the International Society of Thrombosis and Haemostasis in Washington, DC, August 1999.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only